HMR 1043
Latest Information Update: 07 Nov 2003
At a glance
- Originator Aventis
- Class Antibacterials
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 07 Nov 2003 Discontinued - Preclinical for Bacterial infections in France (unspecified route)
- 26 Sep 2000 Preclinical development for Bacterial infections in France (Unknown route)